Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
3
×
national blog main
new york blog main
3
×
san diego blog main
san francisco blog main
astellas pharma
boston blog main
boston top stories
cancer
clinical trials
deals
national top stories
raleigh-durham blog main
san francisco top stories
seattle blog main
seattle top stories
vertex pharmaceuticals
10x genomics
american society of clinical oncology (asco)
anti-inflammatory drugs
arcturus therapeutics
atlas venture
audentes therapeutics
avidity biosciences
avrobio
becton dickinson
bluebird bio
boston
boulder/denver blog main
boulder/denver top stories
brexanolone
camp4 therapeutics
cancer diagnostics
cancer immunotherapy
crispr therapeutics
crispr-cas9
denali therapeutics
detroit blog main
detroit top stories
What
reach
3
×
drug
adding
ago
ahead
aims
ambien
american
annual
asco
attendees
attention
biotech
biotechs
camp’s
cancer
cash
chicago
city
clinical
combinations
community’s
company
considering
data
days
deal
decisions
diagnostic
diagnostics
diseases
dyne
early
expand
expanding
expected
experimental
eyes
focus
fold
Language
unset
Current search:
reach
×
" new york blog main "
×
" life sciences "
×
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
@xconomy.com
6 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More